NCT04529239View on ClinicalTrials.gov

Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

March 1, 2022

Conditions
HealthyType 2 Diabetes Mellitus
Interventions
DEVICE

Abbott Freestyle Libre Pro

Continuous glucose monitoring device to analyze diabetes biomarkers.

Trial Locations (1)

M4W 3R8

Klick Inc., Toronto

Sponsors
All Listed Sponsors
collaborator

Mittal Global Clinical Trial Services

UNKNOWN

lead

Klick Inc.

INDUSTRY

NCT04529239 - Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System | Biotech Hunter | Biotech Hunter